The goal of this prospective, randomized, controlled study is to compare remimazolam besilat/sufentanyl and propofol/sufentanyl in patients during colonoscopic polypectomies procedures. Patients undergoing colonoscopic polypectomies in procedural sedation using remimazolam besylate/sufentanyl are circulatory and respiratory as or more stable when compared with propofol/sufentanyl sedation.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Hemodynamic Stability - Mean Arterial Pressure (MAP)
Timeframe: from enrollment up to 2 hours after the procedure; approximately 2-4 hours per participant.
Hemodynamic Stability - Systolic and Diastolic Blood Pressure
Timeframe: from enrollment up to 2 hours after the procedure; approximately 2-4 hours per participant.
Hemodynamic Stability - Heart Rate
Timeframe: from enrollment up to 2 hours after the procedure; approximately 2-4 hours per participant.
Incidence of Hypotension
Timeframe: from enrollment up to 2 hours after the procedure; approximately 2-4 hours per participant.
Incidence of Bradycardia
Timeframe: from enrollment up to 2 hours after the procedure; approximately 2-4 hours per participant.
Respiratory Stability - Oxygen Saturation (SpOâ‚‚)
Timeframe: from enrollment up to 2 hours after the procedure; approximately 2-4 hours per participant.
Incidence of Respiratory Depression
Timeframe: from enrollment up to 2 hours after the procedure; approximately 2-4 hours per participant.